The Board of Directors of the Company at its meeting held today i.e. Wednesday, August 13, 2025 at Registered Office of the Company has inter-alia has considered and approved the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the quarter ended on 30th June, 2025 .
Financial Results For 30Th June, 2025
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Earlier from Vivanza Biosciences
- Board Meeting Outcome for Board Meeting Outcome
- Vivanza Biosciences Ltd. Press Release Aug 08 2025
- Board Meeting Intimation for Consideration And Approved The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2025.
- Vivanza Biosciences Ltd. Press Release Jul 14 2025
- Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Later from Vivanza Biosciences
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- 43Rd AGM Related Agendas.
- Vivanza Biosciences Ltd. Press Release Aug 28 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On August 30, 2025
- Announcement under Regulation 30 (LODR)-Change in Management
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences